Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

Men with testicular cancer were less likely to experience baldness and severe acne.

DHT affects testicular development and regulates spermatogenesis in some fish.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Finasteride exposure harms tadpole reproduction and hormone balance.

Finasteride negatively affects fish reproduction and gonadal development.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.